Risk of Progression to Type 2 Diabetes Based on Relationship Between Postload Plasma Glucose and Fasting Plasma Glucose Diabetes Division and the Clinical.

Slides:



Advertisements
Similar presentations
Type 2 Diabetes and its Relation to Impaired Fasting and Postload Glucose The Hoorn Study Sarah Kiff Biology Department Eastern CT State University.
Advertisements

1 Prediabetes Screening and Monitoring. 2 Prediabetes Epidemiologic evidence suggests that the complications of T2DM begin early in the progression from.
Type 2 diabetes Years from diagnosis Pre-diabetes Onset Diagnosis Insulin secretion Insulin “efficiency” Ramlo-Halsted BA, Edelman SV.
Gestational diabetes mellitus (GDM), a common medical complication of pregnancy, is defined as “any degree of glucose intolerance with onset or first.
Questions Diabetes. 48. NIDDM response The figure below shows the ‘normal’ response of blood glucose (solid line) and insulin (dashed line) concentrations.
INSULIN STRATEGIES IN TYPE 2 DIABETES. The epidemic of type 2 diabetes and the recognition that achieving specific glycemic goals can substantially reduce.
Blood Glucose Test Dept.of Biochemistry. Determination of glucose concentration is important in the diagnosis and treatment of disorders of carbohydrate.
Normal physiology of pregnancy First trimester-Increased insulin sensitivity. Late 2 nd and 3 rd trimester insulin resistance possible associated with.
OLSON, M.L., ET AL Vitamin D Deficiency in Obese Children an Its Relationship to Glucose Homeostasis J CLIN ENDOCRINOL METAB, 97, , 2012.
1 Prediabetes Burden. 2 Epidemiology: Health Performance Gaps Prevalence Risk factors –Metabolic syndrome –Obesity Clinical risks of prediabetes –Progression.
Prediabetes Burden.
Adiponectinemia, glucose status, insulin secretion and insulin resistance in obese women: influence of weight loss 1) To compare variation in adiponectin.
Effects of vitamin D and calcium supplementation on pancreatic b cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the.
Epidemiology of Diabetes Mellitus by Santi Martini Departemen of Epidemiology Faculty of Public Health University of Airlangga.
The effects of initial and subsequent adiposity status on diabetes mellitus Speaker: Qingtao Meng. MD West China hospital, Chendu, China.
By Hussam A.S. Murad and Khaled A. Mahmoud Department of Pharmacology and Therapeutics Faculty of Medicine, Ain Shams University By Hussam A.S. Murad.
Prevention of Type 2 Diabetes. Hyperglycemia in Type 2 Diabetes: Changing Treatment Paradigms.
Diagnosis of diabetes. Diabetic symptoms Diabetic symptoms + venous sample for : –Random venous ≥ 11.1 mmol/l ( ) –Fasting glucose > 7(
Relationship Between Reported Carbohydrate Intake and Fasting Blood Glucose Lacey Holzer, Richard Tafalla, University of Wisconsin-Stout Abstract Background:
Assessment of Radial Pulse Wave Analysis, Insulin Resistance, and Glucose Homeostasis in African Americans at High Risk for Developing Type 2 Diabetes.
FINDRISC IN SWEDEN The feasibility of the questionnaire in a Swedish population 1,2,3 M.I. Hellgren, 3 P. Friberg, 4 M. Petzold, 1 C. Björkelund, 4 H.
OLSON, M.L., ET AL Vitamin D Deficiency in Obese Children an Its Relationship to Glucose Homeostasis J Clin Endocrinol Metab, 97, , 2012.
Risk of Type 2 Diabetes and It’s Complications Along The Continuum of Fasting Plasma Glucose Gregory A. Nichols, PhD Collaborative Diabetes Education Conference.
Ohara C ( Mph ), Murata A ( MD ), Inoue M ( MD,PhD ), Inoue K ( MD,PhD ) Persons with undiagnosed diabetes have worse profiles of cardiovascular and metabolic.
Type 2 Diabetes in the Elderly: Options for Treatment David Kelley.
ORIGIN Outcome Reduction with an Initial Glargine Intervention (ORIGIN) Trial Overview Large international randomized controlled trial in patients with.
IDC 1.1 Global and National Burden of Diabetes Diabetes Mellitus: classification New (WHO) Screening and Diagnostic Criteria –Diabetes, Impaired Glucose.
Diabetes Prevention for a Heterogeneous Population Richard Arakaki, M.D. Professor of Medicine and Chief, Division of Endocrinology and Metabolism John.
Hyperglycemia and Acute Coronary Syndromes. Cardiovascular disease and diabetes Bell DSH. Diabetes Care. 2003;26: Centers for Disease Control.
Regulation of Blood Sugar Level at the Whole Animal Owen M c Guinness January 11, 2010 Course: MPB 333 Contact info: Phone: Office: 831C Light.
The Effects of Qigong Therapy on Glucose Management in Patients with Type 2 Diabetes Guan-Cheng Sun, Ph.D., Jennifer Lovejoy, Ph.D., Sara Gillham, N.D.
OLSON, M.L., ET AL Vitamin D Deficiency in Obese Children an Its Relationship to Glucose Homeostasis J Clin Endocrinol Metab, 97, , 2012.
OLSON, M.L., ET AL Vitamin D Deficiency in Obese Children an Its Relationship to Glucose Homeostasis J Clin Endocrinol Metab, 97, , 2012.
Journal Club 亀田メディカルセンター 糖尿病内分泌内科 Diabetes and Endocrine Department, Kameda Medical Center 松田 昌文 Matsuda, Masafumi 2008 年1月 10 日 8:20-8:50 B 棟8階 カンファレンス室.
Insulin Resistance Progression to Diabetes. Hypertension: BP >140/90 Dyslipidemia: ◦TG >150 mg/dL (1.7 mmol.L) ◦HDL-C
Diagnosis Glucose tolerance is classified into three broad categories: normal glucose homeostasis, diabetes mellitus, and impaired glucose homeostasis.
Identify the risk factors, diagnosis and prevalence of diabetes in the United States. Describe the function of the pancreas, the intestines and liver.
©1999, Medical Age Publishing, Division of Snyder Healthcare Communications Worldwide, Stamford, Connecticut. All rights reserved. Epidemiology and Diagnosis.
Part 4.
Natural History of Type 2 Diabetes Adapted from International Diabetes Center (IDC), Minneapolis, Minnesota. ObesityIFG*DiabetesUncontrolled Hyperglycemia.
Increased Circulating Levels of Betatrophin in Newly Diagnosed Type 2 Diabetic Patients Featured Article: Hao Hu, Wenjun Sun, Shuqin Yu, Xiafei Hong, Weiyun.
Diabetes Mellitus Introduction to Diabetes Epidemiology.
Trends in Diabetes Incidence: The Framingham Heart Study Featured Article: Tobin M. Abraham, Karol M. Pencina, Michael J. Pencina, and Caroline S. Fox.
Insulin Resistance Progression to Diabetes Part 3.
Prof. Rhee Sang Youl /R3 Cheol Hyun, Lee. Introduction  Chronic exposure to inorganic arsenic may be related to an increased risk of DM.  Specifically,
Whole blood was the sample of choice for analysis However, values for glucose in whole blood are less than in plasma since red blood cells contain only.
TEMPLATE DESIGN © CONTINUOUS GLUCOSE MONITORING, ORAL GLUCOSE TOLERANCE, AND INSULIN – GLUCOSE PARAMETERS IN ADOLESCENTS.
1 Effect of Ramipril on the Incidence of Diabetes The DREAM Trial Investigators N Engl J Med 2006;355 FM R1 윤나리.
Table 1 Descriptive Variables __________________________________________________________________________________________ Variables M (SD) Min. Max. n*
Carbohydrates: Clinical applications Carbohydrate metabolism disorders include: Hyperglycemia: increased blood glucose Hypoglycemia: decreased blood glucose.
1 Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled.
Journal Club 埼玉医科大学 総合医療センター 内分泌・糖尿病内科 Department of Endocrinology and Diabetes, Saitama Medical Center, Saitama Medical University 松田 昌文 Matsuda, Masafumi.
Part 5. Insulin Resistance and  -Cell Dysfunction: Summary Individuals with impaired glucose tolerance –Are maximally or near-maximally insulin resistant.
DIABETES MELLITUS. Diabetes mellitus (DM) is a metabolic disorder resulting from a defect in insulin secretion, insulin action, or both. DM is associated.
Anesthes. 2008;108(3): doi: /ALN.0b013e Figure Legend:
بايو كمستري (م 3) / د . احمد الطويل
Estimation of Glucose Presented By Assist.Lecturer Aseel Ghassan Daoud
GLUCOSE TOLERANCE TEST (GTT)
Essential Amino Acids and Phytosterols promote Improvements in Metabolic Risk Factors in Overweight Individuals with Mild Hyperlipidemia RH Coker1,2,
Screening and Monitoring
Prediabetes Burden.
Type 2 diabetes: Overlap of clinical conditions
Glucose Tolerance Test Physiology lab-3 February, 2018
CHD RISK Glycemia 75g OGTT Time Metabolic Syndrome
Diabetes, prediabetes, and cardiovascular risk: Shifting the paradigm
Effect of metformin on glycemic control, insulin secretion, and insulin sensitivity in T2D. Effect of metformin on glycemic control, insulin secretion,
Prevalence of diabetes (DM) after pancreaticoduodenectomy for PDAC
Insulin secretion/insulin resistance (disposition) index (ΔINS/ΔGLU ÷ IR) in subjects with normal glucose tolerance (NGT), impaired glucose tolerance (IGT),
Odds of incident diabetes by OGTT insulin patterns according to subjects characterized by presence or absence of IGT or dichotomized at the median value.
The hyperbolic relationship between fasting insulin and Si (A) and AIRg and Si (B) for NFG (FPG
Presentation transcript:

Risk of Progression to Type 2 Diabetes Based on Relationship Between Postload Plasma Glucose and Fasting Plasma Glucose Diabetes Division and the Clinical Epidemiology Unit University of Texas Health Science Centre Diabetes Care; Jul 2006; 29 R3 맹치훈

Background Impaired glucose intolerance - time as borderline - “chemical diabetes” Impaired fasting glucose - fasting glucose level 100~125 mg/dL Normal fasting glucose [NFG] and normal glucose tolerance [NGT] - development of DM in 30~40% - preceding ß-cell dysfunction and insulin resistance before onset of IGT - linear relationship of the log of 2-h plasma glucose level  Risk for developing Type 2 DM in substantial number despite of NGT and NFG High risk for progression to overt DM

Objectives Identification of new risk factor for progression of type 2 DM in NGT subjects - study of relationship between the 2-h plasma glucose concentration during OGTT and FPG concentration

Research Design and Methods Subjects - participants of the San Antonio Heart Study - 1,282 aged 25~68 yeare - exclusion of IFG, IGT, overt DM at baseline - complete follow-up examination for 7~8 years Methods - 12-h overnight fasting - OGTT - Blood sampling for plasma glucose and insulin level : baseline time 0, 30, 60, 120 min - HOMA-IR and Matsuda index for insulin resistance - Insulinogenic index : ∆I 0~30 / ∆G 0~30 - Follow-up for 7~8 years

Results Classification A - Division into two groups according to the relationship between the 2-h plasma glucose concentration during OGTT and the FPG concentration 1) 381 subjects : 2-h plasma glucose concentration lower than FPG 2) 901 subjects : 2-h plasma glucose concentration higher than FPG - Odd ratio 2.33  0.75 with addition of insulin resistance and insulinogenic index as independent variables Incidence rates to DM in 7~8 years : 2.9 % Incidence rates to DM in 7~8 years : 5.9 %

Classification B - Division into four groups [ Group I~ IV] according to plasma glucose concentration during OGTT at the time point ( at ’30 ’60 ‘120 min and never) Metabolic Characteristics √

Figure 1 Plasma glucose (A) and Insulin (B) concentration during OGTT at the time ‘0 ’30 ’60 ‘120 and never Insulin resistance as HOMA-IR : increased progressively from Group I to IV Insulin sensitivity as Matsuda Index : declined progressively from Group I to IV Insulinogenic Index ∆I 0~30 / ∆G 0~30 : declined progressively from Group I to IV

Figure 2 Incidence of diabetes after 7~8 years based on the each group I~IV

Classification C – Division into four groups according to 2-h plasma glucose concentration - comparison of the impact of rising 2-h plasma glucose concentration to the development of DM Classification D – Subdivision of each groups according to relationship between FPG and 2-h plasma glucose concentration

Discussion Risk stratification for progression to DM of subjects with NGT and NFG - relationship between FPG concentration and postload plasma glucose concentration - first demonstration - consistent with the degree of insulin resistance and sensitivity according to risk stratification The time reqiured for the plasma glucose level to return to FPG level after glucose ingestion - dependent on insulin response during OGTT and peripheral / hepatic insulin sensitivity - increase insulin resistance + impaired insulin secretion  independent predictors of future development of type 2 DM

Group I : most efficient in normal glucose homeostasis - low ∆Insulin(AUC) / ∆Glucose(AUC) Group II : more insulin resistant than Group I - requirement of a higher ∆Insulin(AUC) / ∆Glucose(AUC) Group III : further worsening of insulin resistance - decreased early-phase insulin secretion calculated by insulinogenic index ( ∆I 0~30 / ∆G 0~30 ) Group IV : most severe insulin resistance + worst ß-cell function Odd ratio Group IV with Group I, II, III (plasma glucose level below FPG at 2-h OGTT) - abolished to just 0.75 by use of insulin sensitivity and secretion as independent variables  stratification based on the FPG and 2-h plasma glucose level ; reflecting insulin resistance and sensitivity

Subjects with Normal OGTT result and stratified to Group IV - not completely “normal” - respect to glucose tolerance and risk for progression to type 2 DM Current notion : safe from risk associated with glucose intolerance in all subjects with 2-h plasma glucose level < 140 mg/dL (OGTT) - not any more consistent with this study Subjects with NGT and NFG and no returning to FPG level after 2-h OGTT - significantly higher risk of progression to type 2 DM - greater insulin resistance and reduced insulin secretion CONCLUSION